🍽️ reboxetine mesylate,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations   |   βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of reboxetine mesylate,(prescription) On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Reduces
species Lactobacillus acidophilus Reduces
species Lactobacillus crispatus Reduces
species Lactobacillus gasseri Reduces
species Lactobacillus helveticus Reduces
species Lactobacillus jensenii Reduces
species Lactobacillus johnsonii Reduces
species Lactobacillus kefiranofaciens Reduces

Bacteria Impacted by reboxetine mesylate,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Terrabacteria group clade Decreases 👪 Source Study
Bacilli class Decreases 👶 Source Study
Clostridia class Decreases 👶 Source Study
Desulfuribacillia class Decreases 👶 Source Study
Dethiobacteria class Decreases 👶 Source Study
Erysipelotrichia class Decreases 👶 Source Study
Limnochordia class Decreases 👶 Source Study
Negativicutes class Decreases 👶 Source Study
Thermolithobacteria class Decreases 👶 Source Study
Tissierellia class Decreases 👶 Source Study
Lactobacillaceae family Decreases 👪 Source Study
Lactobacillus genus Decreases 📓 Source Study Pathogen
Phocaeicola genus Decreases 👪 Source Study
Lachnospira genus Decreases 👪 Source Study
Akkermansia genus Decreases 👪 Source Study
Streptococcus genus Decreases 👪 Source Study
Coprococcus genus Decreases 👪 Source Study
Agathobacter genus Decreases 👪 Source Study
Mediterraneibacter genus Decreases 👪 Source Study
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
unclassified Negativicoccus no rank Decreases ⚗️ Source Study
Bacillota sensu stricto incertae sedis no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
unclassified Bacillota no rank Decreases 👶 Source Study
unclassified Lactobacillus no rank Decreases 👶 Source Study
Eggerthellales order Decreases ⚗️ Source Study
Bacillota phylum Decreases 📓 Source Study
Phocaeicola vulgatus species Decreases 📓 Source Study
Lachnospira eligens species Decreases 📓 Source Study
Akkermansia muciniphila species Decreases 📓 Source Study
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Negativicoccus sp. S5-A15 species Decreases ⚗️ Source Study
ATCC 15434 species Decreases 👶 Source Study
Lactobacillus acetotolerans species Decreases 👶 Source Study
Lactobacillus acidophilus species Decreases 👶 Source Study
Lactobacillus alvei species Decreases 👶 Source Study
Lactobacillus amylolyticus species Decreases 👶 Source Study
Lactobacillus amylovorus species Decreases 👶 Source Study
Lactobacillus animata species Decreases 👶 Source Study
Lactobacillus apis species Decreases 👶 Source Study
Lactobacillus bombicola species Decreases 👶 Source Study
Lactobacillus brevisimilis species Decreases 👶 Source Study
Lactobacillus crispatus species Decreases 👶 Source Study
Lactobacillus delbrueckii species Decreases 👶 Source Study
Lactobacillus equicursoris species Decreases 👶 Source Study
Lactobacillus faeni species Decreases 👶 Source Study
Lactobacillus fornicalis species Decreases 👶 Source Study
Lactobacillus gallinarum species Decreases 👶 Source Study
Lactobacillus gasseri species Decreases 👶 Source Study
Lactobacillus gigeriorum species Decreases 👶 Source Study
Lactobacillus guizhouensis species Decreases 👶 Source Study
Lactobacillus hamsteri species Decreases 👶 Source Study
Lactobacillus helsingborgensis species Decreases 👶 Source Study
Lactobacillus helveticus species Decreases 👶 Source Study
Lactobacillus hominis species Decreases 👶 Source Study
Lactobacillus iners species Decreases 👶 Source Study
Lactobacillus intermedius species Decreases 👶 Source Study
Lactobacillus intestinalis species Decreases 👶 Source Study depression, anhedonia
Lactobacillus japonicus species Decreases 👶 Source Study
Lactobacillus jensenii species Decreases 👶 Source Study
Lactobacillus johnsonii species Decreases 👶 Source Study
Lactobacillus kalixensis species Decreases 👶 Source Study
Lactobacillus kefiranofaciens species Decreases 👶 Source Study
Lactobacillus kitasatonis species Decreases 👶 Source Study
Lactobacillus kullabergensis species Decreases 👶 Source Study
Lactobacillus leichmannii species Decreases 👶 Source Study
Lactobacillus letivazi species Decreases 👶 Source Study
Lactobacillus panisapium species Decreases 👶 Source Study
Lactobacillus paragasseri species Decreases 👶 Source Study
Lactobacillus pasteurii species Decreases 👶 Source Study
Lactobacillus psittaci species Decreases 👶 Source Study
Lactobacillus rodentium species Decreases 👶 Source Study
Lactobacillus rogosae species Decreases 👶 Source Study
Lactobacillus selangorensis species Decreases 👶 Source Study
Lactobacillus sp. 7_1_47FAA species Decreases 👶 Source Study
Lactobacillus sp. MYMRS/TEN2 species Decreases 👶 Source Study
Lactobacillus taiwanensis species Decreases 👶 Source Study
Lactobacillus terrae species Decreases 👶 Source Study
Lactobacillus ultunensis species Decreases 👶 Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Coprococcus comes species Decreases 📓 Source Study
Agathobacter rectalis species Decreases 📓 Source Study
[Ruminococcus] torques species Decreases 📓 Source Study
Lactobacillus casei group species group Decreases 👶 Source Study
Coriobacterineae suborder Decreases ⚗️ Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of reboxetine mesylate,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.5 1.2 -1.4
ADHD 0 1.2 0
Allergic Rhinitis (Hay Fever) 0.5 -0.5
Allergies 0.2 1.2 -5
Alopecia (Hair Loss) 0.5 0.5
Alzheimer's disease 0.2 1.4 -6
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.6 0.8 1
Ankylosing spondylitis 0.3 0.8 -1.67
Anorexia Nervosa 0.2 0.5 -1.5
Antiphospholipid syndrome (APS) 0.1 0.1
Asthma 1.2 -1.2
Atherosclerosis 0.5 0.2 1.5
Atrial fibrillation 1 1
Autism 2 3.2 -0.6
Barrett esophagus cancer 0.1 -0.1
Bipolar Disorder 0.5 0.5 0
Brain Trauma 0.5 -0.5
Carcinoma 0.1 0.1
Celiac Disease 1.3 1 0.3
Cerebral Palsy 0.3 0.3
Chronic Fatigue Syndrome 0.3 1.9 -5.33
Chronic Kidney Disease 0 1.4 0
Chronic Obstructive Pulmonary Disease (COPD) 0.4 0.3 0.33
Chronic Urticaria (Hives) 0.1 0.3 -2
Coagulation / Micro clot triggering bacteria 0.3 0.1 2
Colorectal Cancer 0.6 0 0
Constipation 0.9 0.9
Coronary artery disease 0 0 0
COVID-19 1.6 3.2 -1
Crohn's Disease 0.9 2.5 -1.78
deep vein thrombosis 0.1 -0.1
Depression 2.5 2.4 0.04
Dermatomyositis 0.1 0.5 -4
Eczema 0.6 -0.6
Endometriosis 0.7 1.1 -0.57
Eosinophilic Esophagitis 0.7 -0.7
Epilepsy 0.8 1.5 -0.88
Fibromyalgia 0.6 -0.6
Functional constipation / chronic idiopathic constipation 1.4 1.1 0.27
gallstone disease (gsd) 0.3 0.3
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.1 0.3 2.67
Generalized anxiety disorder 0 0
Glioblastoma 0.1 -0.1
Gout 0.3 0 0
Graves' disease 0.7 0.7 0
Halitosis 0.1 -0.1
Hashimoto's thyroiditis 0.2 0.3 -0.5
Heart Failure 0.2 0.2
Hidradenitis Suppurativa 0.1 0.5 -4
Histamine Issues,Mast Cell Issue, DAO Insufficiency 1 0 0
hypercholesterolemia (High Cholesterol) 0.3 -0.3
hyperglycemia 1 -1
Hyperlipidemia (High Blood Fats) 0.2 0.9 -3.5
hypertension (High Blood Pressure 0.8 0.8 0
Hypothyroidism 0 0
Hypoxia 0.7 0.7
IgA nephropathy (IgAN) 1.1 -1.1
Inflammatory Bowel Disease 1.4 1.9 -0.36
Insomnia 0.8 0.8 0
Intelligence 0 0
Intracranial aneurysms 0.5 -0.5
Irritable Bowel Syndrome 1 2.3 -1.3
Juvenile idiopathic arthritis 0.5 -0.5
Liver Cirrhosis 0.8 0.8 0
Long COVID 2.2 2.3 -0.05
Low bone mineral density 0.3 -0.3
Lung Cancer 0.5 -0.5
ME/CFS with IBS 0.1 0.1 0
ME/CFS without IBS 0.3 0.3
Metabolic Syndrome 1.5 2.4 -0.6
Mood Disorders 3.2 2.4 0.33
multiple chemical sensitivity [MCS] 1 1
Multiple Sclerosis 1.5 2 -0.33
Multiple system atrophy (MSA) 1 1
Neuropathy (all types) 1.3 1.3
neuropsychiatric disorders (PANDAS, PANS) 0.5 -0.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.5 0.7 -0.4
Obesity 1.3 1.4 -0.08
obsessive-compulsive disorder 1.1 0.9 0.22
Osteoarthritis 0.1 0.5 -4
Osteoporosis 0.5 1.3 -1.6
pancreatic cancer 0.1 0.1
Parkinson's Disease 1.4 1.8 -0.29
Polycystic ovary syndrome 1.1 0.2 4.5
Postural orthostatic tachycardia syndrome 0 0
Psoriasis 1.6 0.4 3
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.4 1.3 0.08
Rosacea 0 1 0
Schizophrenia 1.5 0.5 2
scoliosis 0 0.6 0
Sjögren syndrome 0.8 0 0
Sleep Apnea 0.5 0 0
Small Intestinal Bacterial Overgrowth (SIBO) 0.1 0.5 -4
Stress / posttraumatic stress disorder 0.7 0.9 -0.29
Systemic Lupus Erythematosus 0.8 1.7 -1.13
Tic Disorder 0.6 0.6
Tourette syndrome 0.2 0.5 -1.5
Type 1 Diabetes 1.2 1.6 -0.33
Type 2 Diabetes 2.1 2.4 -0.14
Ulcerative colitis 1.5 2 -0.33
Unhealthy Ageing 1.3 0.4 2.25

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)